SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-22-078237
Filing Date
2022-12-07
Accepted
2022-12-07 16:35:27
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea169785-s1_inmedpharma.htm S-1 318768
2 OPINION OF NORTON ROSE FULBRIGHT CANADA LLP ea169785ex5-1_inmedpharma.htm EX-5.1 14514
3 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT, DATED MARCH 1, 2021, BETWEE ea169785ex10-15_inmedpharma.htm EX-10.15 201102
4 CONSENT OF KPMG LLP ea169785ex23-1_inmedpharma.htm EX-23.1 1825
5 FILING FEE TABLE ea169785ex-fee_inmedpharma.htm EX-FILING FEES 17930
6 GRAPHIC image_001.jpg GRAPHIC 5637
7 GRAPHIC ex5-1_001.jpg GRAPHIC 3804
8 GRAPHIC ex10-15_001.jpg GRAPHIC 5773
  Complete submission text file 0001213900-22-078237.txt   576492
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: S-1 | Act: 33 | File No.: 333-268700 | Film No.: 221450555
SIC: 2834 Pharmaceutical Preparations